FDA delays Afrezza decision

Although this news came out a few weeks ago, I missed it. On April 7, 2014, the FDA extended until July 15, 2014 its decision on whether to approve Afrezza for use in the US market.

Even though MannKind says it will need two years (until 2016) to prepare for commercial production, I look forward to this announcement.